NO20091629L - Nye krystaller av (S)-(+)-2-(2-klorofenyl)-2-hydroksy-etylkarbamat - Google Patents

Nye krystaller av (S)-(+)-2-(2-klorofenyl)-2-hydroksy-etylkarbamat

Info

Publication number
NO20091629L
NO20091629L NO20091629A NO20091629A NO20091629L NO 20091629 L NO20091629 L NO 20091629L NO 20091629 A NO20091629 A NO 20091629A NO 20091629 A NO20091629 A NO 20091629A NO 20091629 L NO20091629 L NO 20091629L
Authority
NO
Norway
Prior art keywords
chlorophenyl
hydroxyethylcarbamate
crystal
new crystals
methods
Prior art date
Application number
NO20091629A
Other languages
English (en)
Inventor
Michael Tauber
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of NO20091629L publication Critical patent/NO20091629L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/16—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by singly-bound oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/325—Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C269/00—Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C269/08—Separation; Purification; Stabilisation; Use of additives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/01—Sulfonic acids
    • C07C309/28—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Det beskrives en ny krystall av den aktive farmasøytiske bestanddel (API) (S)-(+)-2-(2-klorfenyl)-2-hydroksy-etyl karbamat. Det beskrives videre fremgangsmåter for fremstilling av denne krystall, farmasøytiske som omfatter denne krystall samt metoder for behandling av en pasient med denne krystall.
NO20091629A 2006-10-10 2009-04-23 Nye krystaller av (S)-(+)-2-(2-klorofenyl)-2-hydroksy-etylkarbamat NO20091629L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US82878506P 2006-10-10 2006-10-10
PCT/US2007/021423 WO2008063284A2 (en) 2006-10-10 2007-10-05 Novel crystal of (s)-(+)-2-(2-chlorophenyl)-2-hydroxy-ethyl carbamate

Publications (1)

Publication Number Publication Date
NO20091629L true NO20091629L (no) 2009-05-06

Family

ID=39430239

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20091629A NO20091629L (no) 2006-10-10 2009-04-23 Nye krystaller av (S)-(+)-2-(2-klorofenyl)-2-hydroksy-etylkarbamat

Country Status (13)

Country Link
US (1) US20080194860A1 (no)
EP (1) EP2076135A2 (no)
JP (1) JP2010505952A (no)
KR (1) KR20090082209A (no)
AU (1) AU2007322339A1 (no)
BR (1) BRPI0717824A2 (no)
CA (1) CA2666159A1 (no)
CO (1) CO6210773A2 (no)
EA (1) EA200970368A1 (no)
IL (1) IL198114A0 (no)
MX (1) MX2009003930A (no)
NO (1) NO20091629L (no)
WO (1) WO2008063284A2 (no)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8609849B1 (en) 2010-11-30 2013-12-17 Fox Chase Chemical Diversity Center, Inc. Hydroxylated sulfamides exhibiting neuroprotective action and their method of use
CN103523248B (zh) * 2013-09-26 2017-03-08 黎明 一种棉产品包装装置

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69112917T2 (de) * 1990-06-15 1996-05-15 Merck & Co Inc Kristallisationsverfahren zur Verbesserung der Kristallstruktur und -grösse.
US5698588A (en) * 1996-01-16 1997-12-16 Yukong Limited Halogen substituted carbamate compounds from 2-phenyl-1,2-ethanediol
WO2000028991A1 (fr) * 1998-11-13 2000-05-25 Fujisawa Pharmaceutical Co., Ltd. Remedes contre le syndrome des ovaires polykystiques
CA2416819C (en) * 2000-07-21 2011-03-22 Ortho-Mcneil Pharmaceutical, Inc. Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain
WO2004078163A2 (en) * 2003-02-28 2004-09-16 Transform Pharmaceuticals, Inc. Pharmaceutical co-crystal compositions of drugs such as carbamazepine, celecoxib, olanzapine, itraconazole, topiramate, modafinil, 5-fluorouracil, hydrochlorothiazide, acetaminophen, aspirin, flurbiprofen, phenytoin and ibuprofen

Also Published As

Publication number Publication date
JP2010505952A (ja) 2010-02-25
EA200970368A1 (ru) 2009-10-30
AU2007322339A1 (en) 2008-05-29
BRPI0717824A2 (pt) 2014-04-15
IL198114A0 (en) 2009-12-24
WO2008063284A2 (en) 2008-05-29
US20080194860A1 (en) 2008-08-14
KR20090082209A (ko) 2009-07-29
WO2008063284A3 (en) 2008-07-10
MX2009003930A (es) 2009-04-23
CA2666159A1 (en) 2008-05-29
EP2076135A2 (en) 2009-07-08
CO6210773A2 (es) 2010-10-20

Similar Documents

Publication Publication Date Title
NO20070067L (no) Pyrrolopyridinderivater
NO20065878L (no) Terapeutiske forbindelser
NO20065904L (no) Terapeutiske forbindelser
EA200501849A1 (ru) Производные пиразолохиназолина: способ получения и применение в качестве ингибиторов киназ
RS52169B (en) STABLE LAKVINIMOD PREPARATIONS
NO20093060L (no) Spirosykliske sykloheksanderivater
EA200970623A1 (ru) Гель, применимый для доставки офтальмологических лекарственных средств
NO20074295L (no) Substituerte gamma lactamer som terapeutiske midler
EA200800798A1 (ru) Фармацевтические композиции, предназначенные для лечения нарушений внутреннего уха
ATE410424T1 (de) Spirocyclische cyclohexan-derivate
WO2007008257A3 (en) Method and apparatus for delivering epinephrine
NO20062450L (no) Analgesiske suspensjoner med kontrollert frigivelse
MY142589A (en) Benzimidazole derivatives : preparation and pharmaceutical applications
EA200970595A1 (ru) Производные замещенных индазолов, активные в качестве ингибиторов киназ
EA200900959A1 (ru) Ингибиторы мек
ATE454372T1 (de) Am histamin-h3-rezeptor wirksame mittel, herstellung und therapeutische anwendungen
BR112012026767A2 (pt) composto, sal farmaceuticamente aceitável de um composto, composição farmacêutica, método para tratar ou previnir distúrbios, e, uso de um composto ou sal
NO20075136L (no) Nye liposompreparater
BRPI0412054A (pt) preparação farmacêutica transdérmica
EA200801826A1 (ru) Дейтерированные производные катехоламина и лекарственные средства, содержащие указанные соединения
BRPI0617655A2 (pt) composto ou um sal farmaceuticamente aceitável do mesmo, ou um isômero óptico do mesmo, uso de um composto, e, formulação farmacêutica
BR112014006763A2 (pt) n-(3-(2-amino-6,6-difluoro-4,4a,5,6,7,7a-hexa-hidro-ciclopenta[e][1,3]oxazin-4-il)-fenil)-amidas como inibidores de bace1
NO20082112L (no) 3-Amino-2-arylpropylazaindoler og deres anvendelse
NO20083836L (no) N-hydroksyakrylamidforbindelser
NO20061033L (no) Sammensetninger og fremgangsmater for levering av biologiske aktive midler

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application